自从植物细胞可培养生长以来,就显示出它在形成次生代谢产物,尤其是药品方面大有前途。这种培养途径具有许多优点:来自植物的药物和中间体,仅在美国市场,一年中就约占90亿美元(例如吗啡、可待因、士的宁碱、马钱子碱、洋地黄毒甙);生物量生产比整体植物快,营养和环境的要求更易控制,且可整年生产;不 Since plant cells can grow in culture, they have shown promise in forming secondary metabolites, especially pharmaceuticals. This approach to culture has many advantages: Medicines and intermediates from plants account for about $ 9 billion a year in the U.S. market alone (eg morphine, codeine, strychnine, strychnine, Flavonoids); biomass production faster than the overall plant, nutrition and environmental requirements easier to control, and can be produced throughout the year;